AR053803A1 - Uso de acido pinolenico - Google Patents
Uso de acido pinolenicoInfo
- Publication number
- AR053803A1 AR053803A1 ARP060100351A ARP060100351A AR053803A1 AR 053803 A1 AR053803 A1 AR 053803A1 AR P060100351 A ARP060100351 A AR P060100351A AR P060100351 A ARP060100351 A AR P060100351A AR 053803 A1 AR053803 A1 AR 053803A1
- Authority
- AR
- Argentina
- Prior art keywords
- pinolenic acid
- acid
- pinolenic
- food
- derivative
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
-
- H—ELECTRICITY
- H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
- H05B—ELECTRIC HEATING; ELECTRIC LIGHT SOURCES NOT OTHERWISE PROVIDED FOR; CIRCUIT ARRANGEMENTS FOR ELECTRIC LIGHT SOURCES, IN GENERAL
- H05B39/00—Circuit arrangements or apparatus for operating incandescent light sources
- H05B39/04—Controlling
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
- A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/13—Coniferophyta (gymnosperms)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Child & Adolescent Psychology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
El ácido pinolénico o un derivado del mismo se pueden usar para el manejo del peso corporal. El ácido pinolénico, por ejemplo se puede usar bajo en la forma de un suplemento alimenticio, de una composicion farmacéutica o de una composicion alimenticia.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP05250517 | 2005-01-31 | ||
GBGB0514463.9A GB0514463D0 (en) | 2005-01-31 | 2005-07-14 | Use of pinolenic acid |
Publications (1)
Publication Number | Publication Date |
---|---|
AR053803A1 true AR053803A1 (es) | 2007-05-23 |
Family
ID=36756867
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP060100351A AR053803A1 (es) | 2005-01-31 | 2006-01-31 | Uso de acido pinolenico |
Country Status (18)
Country | Link |
---|---|
US (1) | US20060172023A1 (es) |
EP (2) | EP1685834B1 (es) |
JP (2) | JP2006213711A (es) |
KR (1) | KR100895800B1 (es) |
CN (1) | CN1853621A (es) |
AR (1) | AR053803A1 (es) |
AT (1) | ATE429218T1 (es) |
AU (1) | AU2006200169B2 (es) |
BR (1) | BRPI0600199A (es) |
CA (1) | CA2533196C (es) |
DE (1) | DE602006006354D1 (es) |
DK (1) | DK1685834T3 (es) |
ES (1) | ES2344017T3 (es) |
GB (1) | GB0514463D0 (es) |
MY (1) | MY148723A (es) |
PL (1) | PL1685834T3 (es) |
RU (1) | RU2358476C2 (es) |
ZA (1) | ZA200600799B (es) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008000440A1 (en) * | 2006-06-27 | 2008-01-03 | Lipid Nutrition B.V. | Use of a polyunsaturated fatty acid compound |
WO2008049198A1 (en) * | 2006-10-27 | 2008-05-02 | Iomedix Development International Srl | Composition for weight loss comprising mulberry leaf, pinolenic acid and salacia oblonga extract |
WO2008090198A1 (en) * | 2007-01-25 | 2008-07-31 | Janssen Pharmaceutica Nv | Use of mtp inhibitors for increasing levels of satiety hormones |
KR20100016613A (ko) * | 2007-04-24 | 2010-02-12 | 리피트 뉴트리션 비.브이. | 음료 조성물 |
US20100129494A1 (en) * | 2007-04-24 | 2010-05-27 | Ellen Maria Elizabeth Mulder | Yoghurt |
WO2008154522A1 (en) * | 2007-06-09 | 2008-12-18 | Arizona Chemical Company | Pinolenic acid compositions, products made thereof, and methods of making pinolenic acid compositions and products |
EP2002730A1 (en) * | 2007-06-11 | 2008-12-17 | Lipid Nutrition B.V. | Pinolenic acid compositions for treating fatty liver |
EP2002731A1 (en) * | 2007-06-11 | 2008-12-17 | Lipid Nutrition B.V. | Use of pinolenic acid for increasing lean body mass |
US20110052760A1 (en) * | 2007-10-29 | 2011-03-03 | Lipid Nutrition B.V. | Soup or sauce composition and process for its production |
EP2055198B1 (en) | 2007-10-29 | 2010-12-08 | Lipid Nutrition B.V. | Dressing composition |
EP2090172A1 (en) * | 2007-10-29 | 2009-08-19 | Lipid Nutrition B.V. | Dough composition |
KR101034458B1 (ko) * | 2008-03-03 | 2011-05-17 | 고려대학교 산학협력단 | 피놀레닌산 고함유 δ5-지방산의 제조방법 |
WO2009118968A1 (ja) * | 2008-03-26 | 2009-10-01 | 日清オイリオグループ株式会社 | 満腹感誘発剤及びこれを含有する飲食品 |
US20110098358A1 (en) * | 2008-06-11 | 2011-04-28 | Ricom Corporation | Human beta3 adrenergic receptor ligand, and food or pharmaceutical product containing the same |
JP6053695B2 (ja) * | 2012-01-19 | 2016-12-27 | 日本水産株式会社 | 食欲抑制剤 |
US9456916B2 (en) | 2013-03-12 | 2016-10-04 | Medibotics Llc | Device for selectively reducing absorption of unhealthy food |
EP2983658B1 (en) | 2013-03-11 | 2024-05-01 | Sciadonics, Inc. | Lipid compositions containing bioactive fatty acids |
US9067070B2 (en) | 2013-03-12 | 2015-06-30 | Medibotics Llc | Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type |
JP2015205846A (ja) * | 2014-04-22 | 2015-11-19 | 出光興産株式会社 | レプチン分泌促進剤 |
CL2015003182A1 (es) * | 2015-10-29 | 2016-04-29 | Univ Concepcion | Un producto nutracéutico modulador del apetito y sensibilizador a la insulina en mamíferos |
WO2017091647A1 (en) * | 2015-11-25 | 2017-06-01 | Sciadonics, Inc. | Lipid formulations containing bioactive fatty acids |
KR101796034B1 (ko) * | 2016-07-28 | 2017-11-09 | 강릉원주대학교 산학협력단 | 증포발효 인삼열매 추출물을 유효성분으로 함유하는 비만 치료용 조성물 |
WO2020028263A1 (en) * | 2018-07-30 | 2020-02-06 | Sciadonics, Inc. | 5,11,14-eicosatrienoic acid compositions and methods for their production |
AR114010A1 (es) * | 2018-10-17 | 2020-07-08 | Team Foods Colombia Sa | Composición lipídica con micronutrientes para la prevención y/o el tratamiento de enfermedades metabólicas |
Family Cites Families (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0070050B1 (en) * | 1981-06-15 | 1984-09-19 | Unilever N.V. | Margarine fat blend |
JPS6158536A (ja) | 1984-08-31 | 1986-03-25 | Nippon Oil & Fats Co Ltd | 栄養組成物 |
JPS61238729A (ja) | 1985-04-16 | 1986-10-24 | Nippon Oil & Fats Co Ltd | コレステロ−ル低下剤 |
US5567751A (en) * | 1995-06-01 | 1996-10-22 | Witco Corporation | Alkyl-tin PVC stabilizers with added aromatic ether alcohol to prevent precipitation |
FR2756465B1 (fr) | 1996-12-03 | 1999-02-19 | D A Noste | Additif alimentaire, composition cosmetique et medicament a base d'huile de graines de pin |
US5813416A (en) | 1997-04-03 | 1998-09-29 | Rudolph; James M. | File with sanitizing agent |
AU775774C (en) * | 1999-04-15 | 2005-05-19 | Kaneka Corporation | Peroxisome proliferator-activated receptor agonist |
US6838431B2 (en) | 1999-07-27 | 2005-01-04 | Pacific Health Laboratories, Inc. | Nutritional intervention composition containing a source of proteinase inhibitor extending post meal satiety |
EP1088552B1 (en) | 1999-09-30 | 2006-04-19 | Loders Croklaan B.V. | Compositions containing pinolenic acid and its use a health component |
ATE258435T1 (de) * | 2000-02-24 | 2004-02-15 | Unilever Nv | Pinolensäure gegen diabetes |
JP2004509143A (ja) | 2000-09-21 | 2004-03-25 | ニュートリション 21、インコーポレイテッド | クロム錯体、共役脂肪酸及び/又は共役脂肪アルコールによる糖尿病の治療、体脂肪減少、インシュリン感受性の改善、高血糖症軽減及び高コレステロール血症軽減の方法及び組成物 |
JP4104814B2 (ja) * | 2000-09-22 | 2008-06-18 | 株式会社カネカ | 配合食用油脂 |
US6429190B1 (en) | 2000-12-15 | 2002-08-06 | Pacifichealth Laboratories, Inc. | Method for extending the satiety of food by adding a nutritional composition designed to stimulate cholecystokinin(CCK) |
DE10102050A1 (de) * | 2001-01-17 | 2002-07-18 | Basf Ag | Zubereitung zur Verbesserung der Nahrungsverwertung |
GB0105069D0 (en) * | 2001-03-01 | 2001-04-18 | Univ Ulster The | Modified peptide |
CN1164292C (zh) | 2001-04-05 | 2004-09-01 | 尹嘉斌 | 治疗高血脂及高血糖类疾病的天然药物 |
SK287423B6 (sk) | 2001-04-30 | 2010-09-07 | Trommsdorff Gmbh & Co. Kg Arzneimittel | Farmaceuticky účinné uridínové estery, ich použitie, spôsob ich prípravy a farmaceutický prostriedok |
US20020192266A1 (en) * | 2001-05-21 | 2002-12-19 | Miles Douglas C. | Therapeutic and nutritive dietary composition and method of use |
US6888016B2 (en) * | 2001-10-16 | 2005-05-03 | Loders Croklaan Usa Llc | Mixtures for stimulating glucose up-take |
US20050038415A1 (en) * | 2003-08-06 | 2005-02-17 | Rohr William L. | Method and apparatus for the treatment of obesity |
EP1570752B1 (en) * | 2004-03-06 | 2008-07-02 | Cognis IP Management GmbH | Verwendung von ungesättigten Fettsäuren zur Verringerung des Appetits oder der Essensaufnahme |
-
2005
- 2005-07-14 GB GBGB0514463.9A patent/GB0514463D0/en not_active Ceased
-
2006
- 2006-01-13 EP EP06250162A patent/EP1685834B1/en not_active Not-in-force
- 2006-01-13 AT AT06250162T patent/ATE429218T1/de not_active IP Right Cessation
- 2006-01-13 PL PL06250162T patent/PL1685834T3/pl unknown
- 2006-01-13 DE DE602006006354T patent/DE602006006354D1/de active Active
- 2006-01-13 ES ES06250162T patent/ES2344017T3/es active Active
- 2006-01-13 EP EP09075115A patent/EP2072048A1/en not_active Withdrawn
- 2006-01-13 DK DK06250162T patent/DK1685834T3/da active
- 2006-01-16 AU AU2006200169A patent/AU2006200169B2/en not_active Ceased
- 2006-01-19 CA CA2533196A patent/CA2533196C/en not_active Expired - Fee Related
- 2006-01-27 ZA ZA200600799A patent/ZA200600799B/en unknown
- 2006-01-27 MY MYPI20060431A patent/MY148723A/en unknown
- 2006-01-28 CN CNA2006100599066A patent/CN1853621A/zh active Pending
- 2006-01-30 JP JP2006021306A patent/JP2006213711A/ja active Pending
- 2006-01-30 US US11/341,517 patent/US20060172023A1/en not_active Abandoned
- 2006-01-30 BR BRPI0600199-8A patent/BRPI0600199A/pt not_active IP Right Cessation
- 2006-01-30 RU RU2006102649/13A patent/RU2358476C2/ru not_active IP Right Cessation
- 2006-01-31 KR KR1020060009434A patent/KR100895800B1/ko not_active IP Right Cessation
- 2006-01-31 AR ARP060100351A patent/AR053803A1/es not_active Application Discontinuation
-
2012
- 2012-02-24 JP JP2012038470A patent/JP2012111778A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
PL1685834T3 (pl) | 2009-09-30 |
ZA200600799B (en) | 2006-09-27 |
AU2006200169A1 (en) | 2006-08-17 |
RU2358476C2 (ru) | 2009-06-20 |
EP1685834B1 (en) | 2009-04-22 |
BRPI0600199A (pt) | 2006-09-19 |
CA2533196A1 (en) | 2006-07-31 |
EP2072048A1 (en) | 2009-06-24 |
RU2006102649A (ru) | 2007-08-20 |
MY148723A (en) | 2013-05-31 |
AU2006200169B2 (en) | 2007-08-23 |
ES2344017T3 (es) | 2010-08-16 |
JP2006213711A (ja) | 2006-08-17 |
EP1685834A1 (en) | 2006-08-02 |
DK1685834T3 (da) | 2009-07-20 |
CN1853621A (zh) | 2006-11-01 |
US20060172023A1 (en) | 2006-08-03 |
KR20060093029A (ko) | 2006-08-23 |
ATE429218T1 (de) | 2009-05-15 |
GB0514463D0 (en) | 2005-08-17 |
CA2533196C (en) | 2011-05-24 |
DE602006006354D1 (de) | 2009-06-04 |
KR100895800B1 (ko) | 2009-05-08 |
JP2012111778A (ja) | 2012-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR053803A1 (es) | Uso de acido pinolenico | |
EA201100969A1 (ru) | Солевые формы органического соединения | |
CL2016002589A1 (es) | Uso del compuesto genz-112638 (eliglustat), inhibidor de glucosilceramida sintasa, en el tratamiento de la enfermedad de gaucher y enfermedad de fabry (divisional de solicitud 201201348). | |
EA201200550A1 (ru) | Фармацевтические композиции, включающие bi-1356 и метформин | |
CR20110609A (es) | Composicion antimicrobiana y metodos relacionados de uso | |
ECSP12011935A (es) | Triazolopiridinas | |
CR11232A (es) | Compuestos de tiazolopirina modulares de sirtuina | |
CL2008001446A1 (es) | Uso de un probiotico o mezcla de los mismos en la elaboracion de una composicion nutricional o farmaceutica para actuar en el colon en un ambiente pre- o post-quirurgico. | |
GT200800250A (es) | Arilimidazolonas y ariltriazolonas sustituidas como inhibidores de receptores de vasopresina | |
DOP2011000264A (es) | Derivados de aminotetralina, composiciones farmaceuticas que los contienen y sus usos en terapia | |
PA8811501A1 (es) | Nuevos derivados de insulina con perfil tiempo/acción extremadamente retardado | |
ECSP088874A (es) | Uso de flibanserina para el tratamiento de trastornos posmenopausicos del deseo sexual | |
CL2010000188A1 (es) | Metodo para el tratamiento de una infeccion en un sujeto que comprende la administracion de 9-[(2,2-dimetil-propilamino)-metil]-minociclina o de una sal de la misma; composicion farmaceutica que comprende dicho compuesto; y su uso. | |
CL2011000214A1 (es) | Composicion farmaceutica que comprende progesterona micronizada y aceite de cartamo tipo ii; y uso para el tratamiento de una condicion relacionada con la insuficiencia de secrecion de progesterona. | |
CU20120171A7 (es) | Triazolopiridinas sustituidas | |
CL2008002049A1 (es) | Compuestos derivados de aminoindol macrociclicos; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c. | |
GT200900240A (es) | Estabilizacion de vitamina b12 | |
PA8846101A1 (es) | Anticuerpos del receptor ii anti-tgf-beta | |
CL2007001752A1 (es) | Compuesto 4-[5(2-amino-etansulfonil)-isoquinolin-7-il]-fenolo una sal farmaceuticamente aceptable o un hidrato o la sal del mismo;composicion farmaceutica que comprende a dicho compuesto,composicion farmaceutica liofilizada;y uso del compuesto como antineiplasico y/o antiviral. | |
NI201100149A (es) | Derivados de tiadiazoles y oxadiazoles, su preparación y su aplicación en terapia. | |
AR082215A1 (es) | Composicion farmaceutica agradable al paladar | |
UY29358A1 (es) | Tiazolidinonas, su preparacion y su uso como medicamento | |
UY29417A1 (es) | Agentes endoparasiticidas | |
UY31768A (es) | Uso de dronedarona o una sal aceptable farmacéuticamente de ésta, para la preparación de un medicamento para regular el nivel de potasio en la sangre | |
CL2009001089A1 (es) | Compuestos derivados de indolo[2,1-a][2]benzacepina; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto para el tratamiento de la hepatitis c. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |